Cargando…

Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic

Detalles Bibliográficos
Autores principales: Khattak, Z., Vlachadis Castles, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324105/
http://dx.doi.org/10.1016/j.hlc.2021.06.048
_version_ 1783731354083524608
author Khattak, Z.
Vlachadis Castles, A.
author_facet Khattak, Z.
Vlachadis Castles, A.
author_sort Khattak, Z.
collection PubMed
description
format Online
Article
Text
id pubmed-8324105
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83241052021-08-02 Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic Khattak, Z. Vlachadis Castles, A. Heart Lung Circ Article Published by Elsevier Ltd. 2021 2021-07-30 /pmc/articles/PMC8324105/ http://dx.doi.org/10.1016/j.hlc.2021.06.048 Text en Copyright © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Khattak, Z.
Vlachadis Castles, A.
Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic
title Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic
title_full Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic
title_fullStr Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic
title_full_unstemmed Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic
title_short Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic
title_sort prescription of angiotensin converting enzyme inhibitors and angiotensin receptor blocking agents in australia during the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324105/
http://dx.doi.org/10.1016/j.hlc.2021.06.048
work_keys_str_mv AT khattakz prescriptionofangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockingagentsinaustraliaduringthecovid19pandemic
AT vlachadiscastlesa prescriptionofangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockingagentsinaustraliaduringthecovid19pandemic